Literature DB >> 24085465

β-Amyloid-evoked apoptotic cell death is mediated through MKK6-p66shc pathway.

Muneesa Bashir1, Arif A Parray, Rafia A Baba, Hina F Bhat, Sehar S Bhat, Umar Mushtaq, Khurshid I Andrabi, Firdous A Khanday.   

Abstract

We have previously shown the involvement of p66shc in mediating apoptosis. Here, we demonstrate the novel mechanism of β-Amyloid-induced toxicity in the mammalian cells. β-Amyloid leads to the phosphorylation of p66shc at the serine 36 residue and activates MKK6, by mediating the phosphorylation at serine 207 residue. Treatment of cells with antioxidants blocks β-Amyloid-induced serine phosphorylation of MKK6, reactive oxygen species (ROS) generation, and hence protected cells against β-Amyloid-induced cell death. Our results indicate that serine phosphorylation of p66shc is carried out by active MKK6. MKK6 knock-down resulted in decreased serine 36 phosphorylation of p66shc. Co-immunoprecipitation results demonstrate a direct physical association between p66shc and WT MKK6, but not with its mutants. Increase in β-Amyloid-induced ROS production was observed in the presence of MKK6 and p66shc, when compared to triple mutant of MKK6 (inactive) and S36 mutant of p66shc. ROS scavengers and knock-down against p66shc, and MKK6 significantly decreased the endogenous level of active p66shc, ROS production, and cell death. Finally, we show that the MKK6-p66shc complex mediates β-Amyloid-evoked apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24085465     DOI: 10.1007/s12017-013-8268-4

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  58 in total

1.  The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway.

Authors:  S Okada; A W Kao; B P Ceresa; P Blaikie; B Margolis; J E Pessin
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

2.  p38 kinase is activated in the Alzheimer's disease brain.

Authors:  K Hensley; R A Floyd; N Y Zheng; R Nael; K A Robinson; X Nguyen; Q N Pye; C A Stewart; J Geddes; W R Markesbery; E Patel; G V Johnson; G Bing
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

3.  P66shc and its downstream Eps8 and Rac1 proteins are upregulated in esophageal cancers.

Authors:  Muneesa Bashir; Deeba Kirmani; Hina F Bhat; Rafia A Baba; Rouf Hamza; Sameer Naqash; Nisar A Wani; Khurshid I Andrabi; Mohammad A Zargar; Firdous A Khanday
Journal:  Cell Commun Signal       Date:  2010-06-18       Impact factor: 5.712

4.  Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

Authors:  T Hartmann; S C Bieger; B Brühl; P J Tienari; N Ida; D Allsop; G W Roberts; C L Masters; C G Dotti; K Unsicker; K Beyreuther
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

5.  beta-amyloid peptides are cytotoxic to astrocytes in culture: a role for oxidative stress.

Authors:  B Brera; A Serrano; M L de Ceballos
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

6.  Differential physiologic responses of alpha7 nicotinic acetylcholine receptors to beta-amyloid1-40 and beta-amyloid1-42.

Authors:  Daniel H S Lee; Hoau-Yan Wang
Journal:  J Neurobiol       Date:  2003-04

7.  Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease.

Authors:  J J Rodríguez; J Witton; M Olabarria; H N Noristani; A Verkhratsky
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

Review 8.  Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress.

Authors:  Laura Canevari; Andrey Y Abramov; Michael R Duchen
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

Review 9.  The GSK3 hypothesis of Alzheimer's disease.

Authors:  Claudie Hooper; Richard Killick; Simon Lovestone
Journal:  J Neurochem       Date:  2007-12-18       Impact factor: 5.372

10.  Sos-mediated activation of rac1 by p66shc.

Authors:  Firdous A Khanday; Lakshmi Santhanam; Kenji Kasuno; Tohru Yamamori; Asma Naqvi; Jeremy Dericco; Artem Bugayenko; Ilwola Mattagajasingh; Andrea Disanza; Giorgio Scita; Kaikobad Irani
Journal:  J Cell Biol       Date:  2006-03-06       Impact factor: 10.539

View more
  10 in total

1.  Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's disease.

Authors:  R Derungs; G G Camici; R D Spescha; T Welt; C Tackenberg; C Späni; F Wirth; A Grimm; A Eckert; R M Nitsch; L Kulic
Journal:  Mol Psychiatry       Date:  2016-07-19       Impact factor: 15.992

2.  TAT-OSBP-1-MKK6(E), a novel TAT-fusion protein with high selectivity for human ovarian cancer, exhibits anti-tumor activity.

Authors:  Jiali Zhong; Jiali Kang; Xiaoxia Wang; Wenyan Jiang; Hua Liao; Jin Yuan
Journal:  Med Oncol       Date:  2015-03-18       Impact factor: 3.064

3.  MAP2K6 remodels chromatin and facilitates reprogramming by activating Gatad2b-phosphorylation dependent heterochromatin loosening.

Authors:  Guangsuo Xing; Zichao Liu; Luyuan Huang; Danyun Zhao; Tao Wang; Hao Yuan; Yi Wu; Linpeng Li; Qi Long; Yanshuang Zhou; Zhihong Hao; Yang Liu; Jianghuan Lu; Shiting Li; Jieying Zhu; Bo Wang; Junwei Wang; Jing Liu; Jiekai Chen; Duanqing Pei; Xingguo Liu; Keshi Chen
Journal:  Cell Death Differ       Date:  2021-11-24       Impact factor: 12.067

Review 4.  New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases.

Authors:  Fabio Di Lisa; Marco Giorgio; Peter Ferdinandy; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2016-04-14       Impact factor: 8.739

5.  Ouabain elicits human glioblastoma cells apoptosis by generating reactive oxygen species in ERK-p66SHC-dependent pathway.

Authors:  Xiaofei Yan; FenLi Liang; Dongmin Li; Jin Zheng
Journal:  Mol Cell Biochem       Date:  2014-09-13       Impact factor: 3.396

6.  The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain.

Authors:  Silvia Fossati; Patrizia Giannoni; Maria E Solesio; Sarah L Cocklin; Erwin Cabrera; Jorge Ghiso; Agueda Rostagno
Journal:  Neurobiol Dis       Date:  2015-11-12       Impact factor: 5.996

Review 7.  p66Shc as a switch in bringing about contrasting responses in cell growth: implications on cell proliferation and apoptosis.

Authors:  Sahar S Bhat; Deepak Anand; Firdous A Khanday
Journal:  Mol Cancer       Date:  2015-04-08       Impact factor: 27.401

8.  The toxicity mechanisms of action of Aβ25-35 in isolated rat cardiac myocytes.

Authors:  Beiru Zhang; Xiaohui Bian; Ping He; Xiaoying Fu; Keiichi Higuchi; Xu Yang; Detian Li
Journal:  Molecules       Date:  2014-08-13       Impact factor: 4.411

Review 9.  p66Shc activation promotes increased oxidative phosphorylation and renders CNS cells more vulnerable to amyloid beta toxicity.

Authors:  Asad Lone; Richard A Harris; Olivia Singh; Dean H Betts; Robert C Cumming
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

10.  Amyloid and Tau Induce Cell Death Independently of TSPO Polymerization and Density Changes.

Authors:  Benjamin B Tournier; Kelly Ceyzériat; Farha N Bouteldja; Philippe Millet
Journal:  ACS Omega       Date:  2021-07-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.